Wei-Wu He, Director at CASI Pharmaceuticals, Inc. (CASI), bought 200,000 shares at $1.86 ($366K) on 2017-10-06, disclosed to the SEC on 2017-10-10.
Open-market purchase of $366k CASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 100,000 | $180K | 49.2% |
| 2 | $1.86 | 100,000 | $186K | 50.8% |
| Total | $1.83 avg | 200,000 | $366K | 100% |
| Filing → |
| CASI | BUY | 2021-08-20 | $614K | — | Filing → |
| CASI | BUY | 2021-03-30 | $12.3M | — | Filing → |
| CASI | BUY | 2020-11-24 | $976K | — | Filing → |